RxDoctor Payments Data

Gerald Fitzgerald, DO

Family Medicine · Largo, FLNPI 1508050196

Payments from drug & device makers

$6,609in general payments, 2019–2025

Across 335 payments — averaging $19.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Merz North America, Inc.$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$546
  • Pfizer$398
  • GSK$344
  • Vanda Pharmaceuticals Inc.$262
  • plus $3K from 40 others

What the payments were for

  • Food & beverage$6,609100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,609 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$228,617
Medicare patients
502
Services billed
34,184

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ergotamine-CaffeineErgotamine Tartrate/Caffeine63$66,114
XifaxanRifaximin19$63,832
Dihydroergotamine Mesylate19$61,889
OzempicSemaglutide49$56,780
EliquisApixaban55$42,794
Naproxen84$29,264
Trelegy ElliptaFluticasone/Umeclidin/Vilanter42$28,163
Nurtec OdtRimegepant Sulfate15$24,942
LinzessLinaclotide16$18,092
Sumatriptan62$18,090
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr24$14,828
XareltoRivaroxaban18$14,485
MyrbetriqMirabegron11$12,999
Incruse ElliptaUmeclidinium Bromide27$9,627
Cyclobenzaprine Hcl142$9,296

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Nurtec Odt$398$67,73570 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$546$63,83219 claims
Novo NordiskOzempic$92$56,78049 claims
GSKTrelegy Ellipta, Anoro Ellipta, Incruse Ellipta$344$52,61893 claims
AbbVieLinzess, Synthroid$1,161$23,69276 claims
Johnson & JohnsonXarelto$42$14,48518 claims
Astellas Pharma US IncMyrbetriq$66$12,99911 claims
Lilly USA, LLCMounjaro$184$8,40611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Largo

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →